Health Care & Life Sciences » Pharmaceuticals | H. Lundbeck A/S

H. Lundbeck A/S

H. Lundbeck A/S ADR
Stock Exchange Other OTC
EPS
 $2.82
Market Cap
 $8.06 B
Shares Outstanding
 199.14 M
Public Float
 -
H. Lundbeck A/S
Stock Exchange Copenhagen Stock Exchange
EPS
 DKK18.15
Market Cap
 DKK53.61 B
Shares Outstanding
 199.14 M
Public Float
 61.22 M
H. Lundbeck A/S
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 199.1 M
Public Float
 -

Profile

Address
Ottiliavej 9
Valby CR 2500
Denmark
Employees -
Website http://www.lundbeck.com
Updated 07/08/2019
H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets.

Financials

View All
Created with Highcharts 5.0.14H. Lundbeck A/SNet Income. Fiscal year is January-December. All values DKK Millions.8558551531535 6945 6941 2111 2112 6242 6243 9073 90720132014201520162017201801k2k3k4k5k6k
Created with Highcharts 5.0.14H. Lundbeck A/SSales/Revenue. Fiscal year is January-December. All values DKK Millions.15 25815 25813 46813 46814 46414 46415 62015 62017 23417 23418 11718 11720132014201520162017201805k10k15k20k

Jørn Møller Mayntzhusen
Director & Senior Manager-Supply Optimization
Ludovic Tranholm Otterbein
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.